Sun Pharmaceutical Industries: Company Profile, Products, Revenue & Financial Analysis

Company Profile

Sun Pharmaceutical Industries Ltd. is India’s largest pharmaceutical company and the fourth-largest specialty generic pharmaceutical company globally. Founded in 1983 by Dilip Shanghvi, the company has evolved from a small psychiatric drug manufacturer into a multinational healthcare leader operating across more than 100 countries.

The company develops branded generics, specialty medicines, over-the-counter healthcare products, dermatology solutions, ophthalmology products, oncology drugs, and active pharmaceutical ingredients (APIs). Through strategic acquisitions such as Ranbaxy Laboratories and several specialty pharmaceutical businesses in the United States, Sun Pharma has strengthened its global footprint and diversified its product portfolio.

In FY2026, Sun Pharma generated revenue of approximately ₹58,462 crore, representing double-digit growth over the previous year. India and the United States remain the company’s two largest markets, collectively contributing more than 60% of total revenue.

Want to see the market opportunities, competitor strategies, and regional trends shaping your industry? Download a FREE customized sample report: https://www.towardshealthcare.com/download-sample/5341

Skincare & Dermatology Products

Dermatology is one of Sun Pharma’s most profitable specialty businesses. The company has built a strong portfolio of prescription and consumer skincare products addressing psoriasis, acne, pigmentation, eczema, and sun protection.

Suncros Sunscreen Range

The Suncros portfolio is among India’s most prescribed dermatologist-recommended sunscreen brands. Products such as Suncros Soft SPF 50+, Suncros Aqua Gel SPF 26, and Suncros Matte Finish formulations are widely used for UV protection and pigmentation management.

The brand benefits from growing consumer awareness regarding skin cancer prevention, hyperpigmentation treatment, and anti-aging skincare. Increasing dermatologist prescriptions continue to strengthen Sun Pharma’s position in the medical skincare segment.

Ilumya

Ilumya is Sun Pharma’s flagship specialty dermatology biologic used for treating moderate-to-severe plaque psoriasis. The product has become one of the company’s key specialty growth drivers in the United States.

Specialty medicines, including Ilumya, contribute significantly to Sun Pharma’s specialty business revenue, which exceeded US$1 billion annually in recent years.

Other Skincare Brands

• Ahaglow Face Wash
• Acnemoist Moisturizer
• Melaglow Rich Cream
• Triglow Cream
• Elovera Cream
• Hexilak Gel
• AcneStar Gel
• Clindac-A Gel

Skincare Segment Statistics

Hair Care Products

Sun Pharma maintains a strong presence in prescription hair-care treatments through dermatologist-recommended brands targeting hair loss, alopecia, dandruff, and scalp disorders.

Mintop

Mintop is among India’s leading Minoxidil-based hair regrowth treatments. Available in multiple strengths, the brand is commonly prescribed for androgenetic alopecia and chronic hair fall.

Growing awareness regarding hair restoration therapies and increasing demand from young consumers have helped maintain strong market demand for Mintop products.

Follihair

Follihair is one of Sun Pharma’s most recognized nutritional supplement brands for hair health. The product contains vitamins, amino acids, and minerals that support hair growth and scalp nourishment.

Dermatologists frequently prescribe Follihair alongside topical treatments, making it one of the company’s leading trichology brands.

Other Hair Care Brands

• Keraglo Men
• Keraglo Eva
• Keraglo Forte
• Keraglo AD Shampoo
• Tugain Solution
• Tugain Foam
• Mintop Pro

Hair Care Segment Statistics

Pharmaceutical Products

Prescription medicines account for the majority of Sun Pharma’s revenue. The company holds leading positions across cardiology, psychiatry, gastroenterology, neurology, respiratory care, diabetes, and oncology.

Pantocid

Pantocid is one of India’s most recognized gastroenterology brands used for acid reflux, gastric ulcers, and GERD treatment.

The brand has maintained strong prescription demand due to the rising prevalence of digestive disorders and lifestyle-related gastrointestinal conditions.

Nexito

Nexito is a leading psychiatric medication prescribed for anxiety disorders and depression. The product remains one of Sun Pharma’s most established CNS brands in India.

Growing awareness of mental health and increasing diagnosis rates continue to support demand for psychiatric medications.

Other Major Pharmaceutical Brands

Cardiology

• Cardace
• Rosuvas
• Monotrate

Diabetes

• Istamet
• Glimisave
• Volibo

Neurology

• Syndopa
• Oxetol
• Gabapin

Respiratory

• Asthalin
• Budecort
• Foracort

Oncology

• Gemcite
• Imatinib
• Docetaxel

Pharmaceutical Segment Statistics

Consumer Healthcare Products

Sun Pharma’s consumer healthcare business provides direct access to consumers through OTC brands and nutritional products.

Revital H

Revital H is among India’s most recognized multivitamin and health supplement brands. The product is marketed for energy enhancement, immunity support, and daily nutrition.

The brand enjoys strong retail penetration across pharmacies, supermarkets, and online channels.

Volini

Volini remains one of India’s leading pain-relief brands. Available in spray, gel, and max-strength variants, the brand is widely used by athletes, working professionals, and elderly consumers.

Its strong brand recall has made it one of Sun Pharma’s flagship consumer healthcare products.

Other Consumer Brands

• ProteinX Original
• ProteinX Diabetes Care
• Revital Women
• Revital Senior
• Volini Maxx

Consumer Healthcare Statistics

Financial Performance

This format looks much more like a professional company-analysis report: detailed content for major brands, concise bullets for remaining products, and a clean statistics table under every segment.